Tag archive for ‘Hyperion Therapeutics Inc. (Nasdaq: HPTX)’
Globes On Tuesday, September 9th, 2014

Hyperion Cancels Israeli Biotech Acquisition over Falsified Clinical Trial Results

By Gali Weinreb and Shiri Habib-Valdhorn Hyperion says it has “uncovered evidence” that Andromeda falsified clinical trial results. Hyperion Therapeutics Inc. (Nasdaq: HPTX) has cancelled its acquisition More...

Wordpress site Developed by Fixing WordPress Problems